Claritin-d 24 hour and Acute upper airway obstruction - a phase IV clinical study of FDA data

Summary:

Acute upper airway obstruction is found among people who take Claritin-d 24 hour, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Claritin-d 24 hour and have Acute upper airway obstruction. It is created by eHealthMe based on reports of 3,560 people who have side effects when taking Claritin-d 24 hour from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 11, 2022

3,560 people reported to have side effects when taking Claritin-d 24 hour.
Among them, 16 people (0.45%) have Acute upper airway obstruction.


What is Claritin-d 24 hour?

Claritin-d 24 hour has active ingredients of loratadine; pseudoephedrine sulfate. It is often used in allergies. eHealthMe is studying from 3,956 Claritin-d 24 hour users for its effectiveness, alternative drugs and more.

What is Acute upper airway obstruction?

Acute upper airway obstruction (blockage occurs in the upper airway) is found to be associated with 2,005 drugs and 1,508 conditions by eHealthMe.

Number of Claritin-d 24 hour and Acute upper airway obstruction reports submitted per year:

Could Claritin-d 24 hour cause Acute upper airway obstruction?

Time on Claritin-d 24 hour when people have Acute upper airway obstruction *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Acute upper airway obstruction when taking Claritin-d 24 hour *:

  • female: 60 %
  • male: 40 %

Age of people who have Acute upper airway obstruction when taking Claritin-d 24 hour *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 23.08 %
  • 30-39: 15.38 %
  • 40-49: 46.15 %
  • 50-59: 0.0 %
  • 60+: 15.38 %

Common drugs people take besides Claritin-d 24 hour *:

  1. Valium: 4 people, 25.00%
  2. Seroquel: 4 people, 25.00%
  3. Chantix: 4 people, 25.00%
  4. Nicotrol: 4 people, 25.00%
  5. Lamictal: 4 people, 25.00%
  6. Vitamin D3: 1 person, 6.25%
  7. Metformin: 1 person, 6.25%
  8. Aspirin: 1 person, 6.25%
  9. Calcium: 1 person, 6.25%
  10. Folic Acid: 1 person, 6.25%

Common side effects people have besides Acute upper airway obstruction *:

  1. Foreign Body Trauma (injury by foreign particle): 6 people, 37.50%
  2. Homicidal Ideation (thoughts about human killing another human): 4 people, 25.00%
  3. Anger: 4 people, 25.00%
  4. Cough: 4 people, 25.00%
  5. Oesophagitis (inflammation of oesophagus): 3 people, 18.75%
  6. Swallowing Difficulty: 3 people, 18.75%
  7. Oesophageal Spasm (contraction of oesophagus): 2 people, 12.50%
  8. Haematemesis (vomiting of blood): 2 people, 12.50%
  9. Indigestion: 2 people, 12.50%
  10. Hypersensitivity: 2 people, 12.50%

Common conditions people have *:

  1. Hypersensitivity: 5 people, 31.25%
  2. Quit Smoking: 4 people, 25.00%
  3. Dizziness: 4 people, 25.00%
  4. Bipolar Disorder (mood disorder): 4 people, 25.00%
  5. Viral Upper Respiratory Tract Infection: 1 person, 6.25%
  6. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 6.25%
  7. Seasonal Allergy (allergic condition due to certain season): 1 person, 6.25%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.25%
  9. Osteoporosis (bones weak and more likely to break): 1 person, 6.25%
  10. High Blood Pressure: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin-d 24 hour and have Acute upper airway obstruction?

Check whether Acute upper airway obstruction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Acute upper airway obstruction and when was it recovered:

Expand to all the drugs that have ingredients of loratadine; pseudoephedrine sulfate:

Alternative drugs to, pros and cons of Claritin-d 24 hour:

Common Claritin-d 24 hour side effects:

Browse all side effects of Claritin-d 24 hour:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Acute upper airway obstruction treatments and more:

COVID vaccines that are related to Acute upper airway obstruction:

Common drugs associated with Acute upper airway obstruction:

All the drugs that are associated with Acute upper airway obstruction:

Common conditions associated with Acute upper airway obstruction:

All the conditions that are associated with Acute upper airway obstruction:

How the study uses the data?

The study uses data from the FDA. It is based on loratadine; pseudoephedrine sulfate (the active ingredients of Claritin-d 24 hour) and Claritin-d 24 hour (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: